McKesson Acquires US Oncology

1/18/2011, R. Morton

The McKesson Corporation recently completed its acquisition of US Oncology, a company diligent in its efforts to provide invaluable resources, approaches and increases in the effectiveness of cancer care. McKesson is a conglomerate of businesses, dedicated to delivering the vital medicines, supplies and information technologies to the healthcare industry. According to Healthcare IT News, the acquisition was valued at $2.2 billion and allows McKesson to deliver a more comprehensive set of oncology practice-management resources. These resources will help oncologists enhance their fiscal operations, provide advancements in the science of cancer care and offer high quality care options for cancer patients. Bruce Broussard, CEO of US Oncology, is slated to head the combined organization and will be headquartered in Texas. The unified company will also have continued operations in the San Francisco Bay Area and other locations throughout the country.